Opening keynote presentation: The future of cell and gene therapies

Monday, November 2, 2020 9:00 AM to 9:20 AM · 20 min. (UTC)
World Immunotherapy Congress
Keynote sessions: Immunotherapy
Presentation

Information

  • Novartis’ vision for B-cell malignancies, with Kymriah and beyond
  • Exploring new CAR-T platforms, targets, and disease areas

Stefan Hendriks, SVP, Head of Cell & Gene Therapy, Novartis

Unfortunately, Stefan is not available live to take questions.

Log in

See all the content and easy-to-use features by logging in or registering!